May 2019 By PsychDB.com

Pimavanserin (Nuplazid)

Pimavanserin (Tradename: Nuplazid) is an atypical antipsychotic used in the treatment of Parkinson's disease psychosis in the USA.

Unlike other antipsychotics, pimanvaserin is not a dopamine receptor antagonist. It is a highly selective serotonin 5-HT2A receptor antagonist.